Mafalda V Moreira

No ORCID on file · 3 papers in corpus
lab-animal 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1783780

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by altered follicular development and metabolic dysfunction, frequently exacerbated by obesity. The follicular fluid (FF) microenvironment plays a critical role in supporting ooc…

other 2024
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2024.1408879

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women at childbearing age. Anti-Müllerian hormone (AMH) is a widely accepted sensitive marker of ovarian reserve, which has been suggested that could also act as biomarke…

meta-analysis 2023
Reviews in endocrine & metabolic disorders ·doi:10.1007/s11154-023-09819-z

Polycystic ovary syndrome (PCOS) is recognized as one of the most prevalent endocrinopathy in women at reproductive age. As affected women tend to have poorer assisted reproductive technology (ART) outcomes, PCOS has been suggested to endan…